2023 Common Warrants
Issued 2023
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 29 of Aligos Therapeutics, Inc.'s SEC filings and found 4 warrant series and 3 shelf registrations on file for ALGS. The latest dilution event on file is a registration statement on Apr 3, 2025. Analysis updated Oct 7, 2026.
Raise routes on file: effective shelf · latest dilution event 579 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Apr 3, 2025 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2023
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2023
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z